These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 9405687)

  • 1. A system for functional analysis of Ebola virus glycoprotein.
    Takada A; Robison C; Goto H; Sanchez A; Murti KG; Whitt MA; Kawaoka Y
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14764-9. PubMed ID: 9405687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
    Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
    Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
    Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y
    J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test.
    Ogino M; Ebihara H; Lee BH; Araki K; Lundkvist A; Kawaoka Y; Yoshimatsu K; Arikawa J
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):154-60. PubMed ID: 12522053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
    Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y
    J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
    Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding.
    Klenk K; Roberts SR
    Virus Res; 2002 Dec; 90(1-2):327-35. PubMed ID: 12457986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles.
    Dalton KP; Rose JK
    Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.
    Takada A; Feldmann H; Stroeher U; Bray M; Watanabe S; Ito H; McGregor M; Kawaoka Y
    J Virol; 2003 Jan; 77(2):1069-74. PubMed ID: 12502822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.
    Kahn JS; Roberts A; Weibel C; Buonocore L; Rose JK
    J Virol; 2001 Nov; 75(22):11079-87. PubMed ID: 11602747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of Ebola virus L-domains using VSV recombinants.
    Irie T; Licata JM; Harty RN
    Virology; 2005 Jun; 336(2):291-8. PubMed ID: 15892969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of recombinant VSV-Ebola virus vaccine vector in pigs.
    de Wit E; Marzi A; Bushmaker T; Brining D; Scott D; Richt JA; Geisbert TW; Feldmann H
    Emerg Infect Dis; 2015 Apr; 21(4):702-4. PubMed ID: 25811738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectivity-enhancing antibodies to Ebola virus glycoprotein.
    Takada A; Watanabe S; Okazaki K; Kida H; Kawaoka Y
    J Virol; 2001 Mar; 75(5):2324-30. PubMed ID: 11160735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.
    Garbutt M; Liebscher R; Wahl-Jensen V; Jones S; Möller P; Wagner R; Volchkov V; Klenk HD; Feldmann H; Ströher U
    J Virol; 2004 May; 78(10):5458-65. PubMed ID: 15113924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
    Rogalin HB; Heldwein EE
    J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.
    Lai L; Davey R; Beck A; Xu Y; Suffredini AF; Palmore T; Kabbani S; Rogers S; Kobinger G; Alimonti J; Link CJ; Rubinson L; Ströher U; Wolcott M; Dorman W; Uyeki TM; Feldmann H; Lane HC; Mulligan MJ
    JAMA; 2015 Mar 24-31; 313(12):1249-55. PubMed ID: 25742465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of vaccine-induced protective immunity against Ebola virus disease.
    Medaglini D; Santoro F; Siegrist CA
    Semin Immunol; 2018 Oct; 39():65-72. PubMed ID: 30041831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.